Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 340

1.

Severe Fever with Thrombocytopenia Syndrome Virus RNA in Semen, Japan.

Koga S, Takazono T, Ando T, Hayasaka D, Tashiro M, Saijo T, Kurihara S, Sekino M, Yamamoto K, Imamura Y, Miyazaki T, Yanagihara K, Morita K, Izumikawa K, Mukae H.

Emerg Infect Dis. 2019 Nov;25(11):2127-2128. doi: 10.3201/eid2511.190061.

2.

Daily practice and prognostic factors for pneumonia caused by methicillin-resistant Staphylococcus aureus in Japan: A multicenter prospective observational cohort study.

Miyazaki T, Yanagihara K, Kakeya H, Izumikawa K, Mukae H, Shindo Y, Yamamoto Y, Tateda K, Tomono K, Ishida T, Hasegawa Y, Niki Y, Watanabe A, Soma K, Kohno S.

J Infect Chemother. 2019 Sep 28. pii: S1341-321X(19)30268-5. doi: 10.1016/j.jiac.2019.08.018. [Epub ahead of print]

3.

Exploring the microbiota of upper respiratory tract during the development of pneumonia in a mouse model.

Morinaga Y, Take Y, Sasaki D, Ota K, Kaku N, Uno N, Sakamoto K, Kosai K, Miyazaki T, Hasegawa H, Izumikawa K, Mukae H, Yanagihara K.

PLoS One. 2019 Sep 27;14(9):e0222589. doi: 10.1371/journal.pone.0222589. eCollection 2019.

4.

Munchausen syndrome mimicking refractory subcutaneous abscess with bacteremia, diagnosed by repetitive element sequence-based polymerase chain reaction: a case report.

Iwanaga N, Yamamoto K, Takazono T, Saijo T, Imamura Y, Miyazaki T, Izumikawa K, Yamamoto Y, Yanagihara K, Yasuoka A, Mukae H.

J Med Case Rep. 2019 Sep 12;13(1):287. doi: 10.1186/s13256-019-2212-7.

5.

LYAR potentiates rRNA synthesis by recruiting BRD2/4 and the MYST-type acetyltransferase KAT7 to rDNA.

Izumikawa K, Ishikawa H, Yoshikawa H, Fujiyama S, Watanabe A, Aburatani H, Tachikawa H, Hayano T, Miura Y, Isobe T, Simpson RJ, Li L, Min J, Takahashi N.

Nucleic Acids Res. 2019 Nov 4;47(19):10357-10372. doi: 10.1093/nar/gkz747.

6.

Evaluation of Candida peritonitis with underlying peritoneal fibrosis and efficacy of micafungin in murine models of intra-abdominal candidiasis.

Ashizawa N, Miyazaki T, Abe S, Takazono T, Saijo T, Obata Y, Shimamura S, Yamamoto K, Imamura Y, Koji T, Nishino T, Izumikawa K, Yanagihara K, Kohno S, Mukae H.

Sci Rep. 2019 Jun 27;9(1):9331. doi: 10.1038/s41598-019-45776-x.

7.

The Novel Arylamidine T-2307 Selectively Disrupts Yeast Mitochondrial Function by Inhibiting Respiratory Chain Complexes.

Yamashita K, Miyazaki T, Fukuda Y, Mitsuyama J, Saijo T, Shimamura S, Yamamoto K, Imamura Y, Izumikawa K, Yanagihara K, Kohno S, Mukae H.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00374-19. doi: 10.1128/AAC.00374-19. Print 2019 Aug.

8.

Antibody Treatment against Angiopoietin-Like 4 Reduces Pulmonary Edema and Injury in Secondary Pneumococcal Pneumonia.

Li L, Foo BJW, Kwok KW, Sakamoto N, Mukae H, Izumikawa K, Mandard S, Quenot JP, Lagrost L, Teh WK, Singh Kohli G, Zhu P, Choi H, Buist ML, Seet JE, Yang L, He F, Kwong Chow VT, Tan NS.

MBio. 2019 Jun 4;10(3). pii: e02469-18. doi: 10.1128/mBio.02469-18.

9.

The efficacy and safety of sitafloxacin and garenoxacin for the treatment of pneumonia in elderly patients: A randomized, multicenter, open-label trial.

Miyazaki T, Nakamura S, Hashiguchi K, Kobayashi T, Fukushima K, Fukuda Y, Kondo A, Inoue Y, Koga H, Sasaki E, Nagayoshi Y, Higashiyama Y, Yoshida M, Takazono T, Saijo T, Morinaga Y, Yamamoto K, Imamura Y, Mikushi S, Izumikawa K, Yanagihara K, Kohno S, Mukae H.

J Infect Chemother. 2019 Nov;25(11):886-893. doi: 10.1016/j.jiac.2019.04.019. Epub 2019 May 18.

10.

Efficacy and safety of cefditoren pivoxil for exacerbations of chronic obstructive pulmonary disease: A prospective multicenter interventional study.

Miyazaki T, Fukushima K, Hashiguchi K, Inoue Y, Mihara T, Sawai T, Suyama N, Kobayashi T, Kondo A, Fukuda Y, Harada Y, Sasaki E, Kaku N, Ide S, Takazono T, Saijo T, Kosai K, Morinaga Y, Nakamura S, Yamamoto K, Imamura Y, Izumikawa K, Yanagihara K, Kohno S, Mukae H.

J Infect Chemother. 2019 Sep;25(9):702-707. doi: 10.1016/j.jiac.2019.03.018. Epub 2019 Apr 11.

11.

Selection of oral antifungals for initial maintenance therapy in chronic pulmonary aspergillosis: A longitudinal analysis.

Tashiro M, Takazono T, Saijo T, Yamamoto K, Imamura Y, Miyazaki T, Kakeya H, Ando T, Ogawa K, Kishi K, Tokimatsu I, Hayashi Y, Fujiuchi S, Yanagihara K, Miyazaki Y, Ichihara K, Mukae H, Kohno S, Izumikawa K.

Clin Infect Dis. 2019 Apr 9. pii: ciz287. doi: 10.1093/cid/ciz287. [Epub ahead of print]

PMID:
30959519
12.

Evaluation of Aspergillus-Specific Lateral-Flow Device Test Using Serum and Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis.

Takazono T, Ito Y, Tashiro M, Nishimura K, Saijo T, Yamamoto K, Imamura Y, Miyazaki T, Yanagihara K, Mukae H, Izumikawa K.

J Clin Microbiol. 2019 Apr 26;57(5). pii: e00095-19. doi: 10.1128/JCM.00095-19. Print 2019 May.

13.

Viral load and inflammatory cytokine dynamics associated with the prognosis of severe fever with thrombocytopenia syndrome virus infection: An autopsy case.

Nakamura S, Iwanaga N, Hara S, Shimada S, Kashima Y, Hayasaka D, Abe K, Izumikawa K, Yanagihara K, Miyazaki Y, Morita K, Kohno S, Mukae H.

J Infect Chemother. 2019 Jun;25(6):480-484. doi: 10.1016/j.jiac.2019.01.013. Epub 2019 Feb 26.

PMID:
30824300
14.

Autophagy-Inducing Factor Atg1 Is Required for Virulence in the Pathogenic Fungus Candida glabrata.

Shimamura S, Miyazaki T, Tashiro M, Takazono T, Saijo T, Yamamoto K, Imamura Y, Izumikawa K, Yanagihara K, Kohno S, Mukae H.

Front Microbiol. 2019 Jan 25;10:27. doi: 10.3389/fmicb.2019.00027. eCollection 2019.

15.

TDP-43 regulates site-specific 2'-O-methylation of U1 and U2 snRNAs via controlling the Cajal body localization of a subset of C/D scaRNAs.

Izumikawa K, Nobe Y, Ishikawa H, Yamauchi Y, Taoka M, Sato K, Nakayama H, Simpson RJ, Isobe T, Takahashi N.

Nucleic Acids Res. 2019 Mar 18;47(5):2487-2505. doi: 10.1093/nar/gkz086.

16.

[A case of small intestinal ulcer caused by non-steroidal anti-inflammatory drugs patch].

Aoyama Y, Takahashi S, Inaba T, Izumikawa K, Nakamura S.

Nihon Shokakibyo Gakkai Zasshi. 2019;116(2):145-152. doi: 10.11405/nisshoshi.116.145. Japanese.

PMID:
30745552
17.

Clinical features and cause analysis of false positive results of Aspergillus galactomannan assay in pulmonary cryptococcosis patients.

Takazono T, Saijo T, Ashizawa N, Oshima K, Nishimura K, Tashiro M, Yamamoto K, Imamura Y, Miyazaki T, Yanagihara K, Mukae H, Izumikawa K, Sheppard DC.

Eur J Clin Microbiol Infect Dis. 2019 Apr;38(4):735-741. doi: 10.1007/s10096-019-03469-3. Epub 2019 Jan 25.

PMID:
30684164
18.

Vacuolar proton-translocating ATPase is required for antifungal resistance and virulence of Candida glabrata.

Minematsu A, Miyazaki T, Shimamura S, Nishikawa H, Nakayama H, Takazono T, Saijo T, Yamamoto K, Imamura Y, Yanagihara K, Kohno S, Mukae H, Izumikawa K.

PLoS One. 2019 Jan 23;14(1):e0210883. doi: 10.1371/journal.pone.0210883. eCollection 2019.

19.

Infection control after and during natural disaster.

Izumikawa K.

Acute Med Surg. 2018 Sep 23;6(1):5-11. doi: 10.1002/ams2.367. eCollection 2019 Jan. Review.

20.

Molecular and epidemiological analysis of IMP-1 metallo-β-lactamase-producing Klebsiella pneumoniae in a tertiary care hospital in Japan.

Yamakawa H, Kosai K, Akamatsu N, Matsuda J, Kaku N, Uno N, Morinaga Y, Hasegawa H, Tsubouchi T, Kaneko Y, Miyazaki T, Izumikawa K, Mukae H, Yanagihara K.

J Infect Chemother. 2019 Apr;25(4):240-246. doi: 10.1016/j.jiac.2018.11.012. Epub 2019 Jan 2.

PMID:
30611637
21.

Distinct shed microvesicle and exosome microRNA signatures reveal diagnostic markers for colorectal cancer.

Chen M, Xu R, Rai A, Suwakulsiri W, Izumikawa K, Ishikawa H, Greening DW, Takahashi N, Simpson RJ.

PLoS One. 2019 Jan 4;14(1):e0210003. doi: 10.1371/journal.pone.0210003. eCollection 2019.

22.

SAMMSON fosters cancer cell fitness by concertedly enhancing mitochondrial and cytosolic translation.

Vendramin R, Verheyden Y, Ishikawa H, Goedert L, Nicolas E, Saraf K, Armaos A, Delli Ponti R, Izumikawa K, Mestdagh P, Lafontaine DLJ, Tartaglia GG, Takahashi N, Marine JC, Leucci E.

Nat Struct Mol Biol. 2018 Nov;25(11):1035-1046. doi: 10.1038/s41594-018-0143-4. Epub 2018 Oct 29.

23.

Risk Factors for Acquisition of Fluoroquinolone or Aminoglycoside Resistance in Addition to Carbapenem Resistance in Pseudomonas aeruginosa.

Kosai K, Kaku N, Uno N, Saijo T, Morinaga Y, Imamura Y, Hasegawa H, Miyazaki T, Izumikawa K, Mukae H, Yanagihara K.

Open Microbiol J. 2018 Sep 28;12:321-322. doi: 10.2174/1874285801812010321. eCollection 2018. No abstract available.

24.

Landscape of the complete RNA chemical modifications in the human 80S ribosome.

Taoka M, Nobe Y, Yamaki Y, Sato K, Ishikawa H, Izumikawa K, Yamauchi Y, Hirota K, Nakayama H, Takahashi N, Isobe T.

Nucleic Acids Res. 2018 Oct 12;46(18):9289-9298. doi: 10.1093/nar/gky811.

25.

Primary Oral Mucormycosis Due to Rhizopus microsporus after Allogeneic Stem Cell Transplantation.

Sakamoto H, Itonaga H, Sawayama Y, Taguchi J, Saijo T, Kuwatsuka S, Hashisako M, Kinoshita N, Oishi M, Doi H, Kosai K, Nishimoto K, Tanaka K, Yanagihara K, Mukae H, Izumikawa K, Miyazaki Y.

Intern Med. 2018;57(17):2567-2571. doi: 10.2169/internalmedicine.0474-17. Epub 2018 Sep 1.

26.

Recent Advances in Diagnosing Chronic Pulmonary Aspergillosis.

Takazono T, Izumikawa K.

Front Microbiol. 2018 Aug 17;9:1810. doi: 10.3389/fmicb.2018.01810. eCollection 2018. Review.

27.

Pulmonary Scedosporium apiospermum Infection with Pulmonary Tumorlet in an Immunocompetent Patient.

Motokawa N, Miyazaki T, Hara A, Fukuda Y, Morino S, Nakamura H, Iwasaki K, Soda H, Izumikawa K, Yanagihara K, Ohno H, Miyazaki Y, Kohno S, Mukae H.

Intern Med. 2018 Dec 1;57(23):3485-3490. doi: 10.2169/internalmedicine.1239-18. Epub 2018 Aug 10.

28.

Performance evaluation of the MALDI Biotyper Selective Testing of Antibiotic Resistance-β-Lactamase (MBT STAR-BL) assay for the detection of IMP metallo-β-lactamase activity in Enterobacteriaceae.

Kawamoto Y, Kosai K, Yamakawa H, Kaku N, Uno N, Morinaga Y, Hasegawa H, Miyazaki T, Izumikawa K, Mukae H, Yanagihara K.

Diagn Microbiol Infect Dis. 2018 Dec;92(4):275-278. doi: 10.1016/j.diagmicrobio.2018.06.018. Epub 2018 Jun 27.

PMID:
30041842
29.

Case Definition of Chronic Pulmonary Aspergillosis in Resource-Constrained Settings.

Denning DW, Page ID, Chakaya J, Jabeen K, Jude CM, Cornet M, Alastruey-Izquierdo A, Bongomin F, Bowyer P, Chakrabarti A, Gago S, Guto J, Hochhegger B, Hoenigl M, Irfan M, Irurhe N, Izumikawa K, Kirenga B, Manduku V, Moazam S, Oladele RO, Richardson MD, Tudela JLR, Rozaliyani A, Salzer HJF, Sawyer R, Simukulwa NF, Skrahina A, Sriruttan C, Setianingrum F, Wilopo BAP, Cole DC, Getahun H.

Emerg Infect Dis. 2018 Aug;24(8). doi: 10.3201/eid2408.171312.

30.

Evaluation of FilmArray respiratory panel multiplex polymerase chain reaction assay for detection of pathogens in adult outpatients with acute respiratory tract infection.

Kaku N, Hashiguchi K, Iwanaga Y, Akamatsu N, Matsuda J, Kosai K, Uno N, Morinaga Y, Kitazaki T, Hasegawa H, Miyazaki T, Fukuda M, Izumikawa K, Mukae H, Yanagihara K.

J Infect Chemother. 2018 Sep;24(9):734-738. doi: 10.1016/j.jiac.2018.05.006. Epub 2018 Jun 9.

PMID:
29895452
31.

Modulating the expression of Chtop, a versatile regulator of gene-specific transcription and mRNA export.

Izumikawa K, Ishikawa H, Simpson RJ, Takahashi N.

RNA Biol. 2018;15(7):849-855. doi: 10.1080/15476286.2018.1465795. Epub 2018 May 11. Review.

32.

Bleeding in patients who underwent scheduled second-look endoscopy 5 days after endoscopic submucosal dissection for gastric lesions.

Izumikawa K, Iwamuro M, Inaba T, Ishikawa S, Kuwaki K, Sakakihara I, Yamamoto K, Takahashi S, Tanaka S, Wato M, Okada H.

BMC Gastroenterol. 2018 Apr 10;18(1):46. doi: 10.1186/s12876-018-0774-2.

33.

Clinicopathological examination of ESD as salvage therapy for esophageal cancer after definitive chemo-radiation therapy.

Kagawa T, Ishikawa S, Inaba T, Colvin M, Toyosawa J, Aoyama Y, Ishida M, Kuraoka S, Okamoto K, Sakakihara I, Izumikawa K, Yamamoto K, Takahashi S, Tanaka S, Matsuura M, Hasui T, Wato M, Ando M, Nakamura S, Mizobuchi K.

Endosc Int Open. 2018 Apr;6(4):E450-E461. doi: 10.1055/s-0044-102296. Epub 2018 Mar 29.

34.

Clinical and Microbiological Characteristics of Candida guilliermondii and Candida fermentati.

Hirayama T, Miyazaki T, Yamagishi Y, Mikamo H, Ueda T, Nakajima K, Takesue Y, Higashi Y, Yamamoto Y, Kimura M, Araoka H, Taniguchi S, Fukuda Y, Matsuo Y, Furutani A, Yamashita K, Takazono T, Saijo T, Shimamura S, Yamamoto K, Imamura Y, Izumikawa K, Yanagihara K, Kohno S, Mukae H.

Antimicrob Agents Chemother. 2018 May 25;62(6). pii: e02528-17. doi: 10.1128/AAC.02528-17. Print 2018 Jun.

35.

In Vitro Activity of Lascufloxacin against Streptococcus pneumoniae with Mutations in the Quinolone Resistance-Determining Regions.

Murata M, Kosai K, Yamauchi S, Sasaki D, Kaku N, Uno N, Morinaga Y, Hasegawa H, Miyazaki T, Izumikawa K, Mukae H, Yanagihara K.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e01971-17. doi: 10.1128/AAC.01971-17. Print 2018 Apr.

36.

Adjunctive corticosteroid therapy for inpatients with Mycoplasma pneumoniae pneumonia.

Tashiro M, Fushimi K, Kawano K, Takazono T, Saijo T, Yamamoto K, Kurihara S, Imamura Y, Miyazaki T, Yanagihara K, Mukae H, Izumikawa K.

BMC Pulm Med. 2017 Dec 29;17(1):219. doi: 10.1186/s12890-017-0566-4.

37.

[Survival Strategies of Aspergillus in the Human Body].

Tashiro M, Izumikawa K.

Med Mycol J. 2017;58(4):J133-J139. doi: 10.3314/mmj.17.019. Review. Japanese.

38.

Truncated forms of U2 snRNA (U2-tfs) are shunted toward a novel uridylylation pathway that differs from the degradation pathway for U1-tfs.

Ishikawa H, Nobe Y, Izumikawa K, Taoka M, Yamauchi Y, Nakayama H, Simpson RJ, Isobe T, Takahash N.

RNA Biol. 2018 Feb 1;15(2):261-268. doi: 10.1080/15476286.2017.1408766. Epub 2017 Dec 15.

39.

Comparison of Efficacy of Antimicrobial Agents Among Hospitalized Patients With Mycoplasma pneumoniae Pneumonia in Japan During Large Epidemics of Macrolide-Resistant M. pneumoniae Infections: A Nationwide Observational Study.

Tashiro M, Fushimi K, Kawano K, Takazono T, Saijo T, Yamamoto K, Kurihara S, Imamura Y, Miyazaki T, Yanagihara K, Mukae H, Izumikawa K.

Clin Infect Dis. 2017 Nov 13;65(11):1837-1842. doi: 10.1093/cid/cix695.

PMID:
29020161
40.

TDP-43 stabilises the processing intermediates of mitochondrial transcripts.

Izumikawa K, Nobe Y, Yoshikawa H, Ishikawa H, Miura Y, Nakayama H, Nonaka T, Hasegawa M, Egawa N, Inoue H, Nishikawa K, Yamano K, Simpson RJ, Taoka M, Yamauchi Y, Isobe T, Takahashi N.

Sci Rep. 2017 Aug 9;7(1):7709. doi: 10.1038/s41598-017-06953-y.

41.

Efficacy and Safety of Intravenous Peramivir Compared With Oseltamivir in High-Risk Patients Infected With Influenza A and B Viruses: A Multicenter Randomized Controlled Study.

Nakamura S, Miyazaki T, Izumikawa K, Kakeya H, Saisho Y, Yanagihara K, Miyazaki Y, Mukae H, Kohno S.

Open Forum Infect Dis. 2017 Jun 19;4(3):ofx129. doi: 10.1093/ofid/ofx129. eCollection 2017 Summer.

42.

Performance evaluation of the Verigene®Clostridium difficile nucleic acid test, an automated multiplex molecular testing system for detection of C. difficile toxin.

Kosai K, Iwanaga Y, Akamatsu N, Okada Y, Kaku N, Uno N, Morinaga Y, Hasegawa H, Miyazaki T, Izumikawa K, Mukae H, Yanagihara K.

J Infect Chemother. 2017 Oct;23(10):674-677. doi: 10.1016/j.jiac.2017.07.002. Epub 2017 Jul 24.

PMID:
28751156
43.

Tedizolid inhibits MUC5AC production induced by methicillin-resistant Staphylococcus aureus in human airway epithelial cells.

Takeda K, Kaku N, Morinaga Y, Kosai K, Uno N, Imamura Y, Hasegawa H, Miyazaki T, Izumikawa K, Mukae H, Yanagihara K.

J Infect Chemother. 2017 Sep;23(9):598-603. doi: 10.1016/j.jiac.2017.04.015. Epub 2017 Jul 17.

PMID:
28729052
44.

Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species.

Nagayoshi Y, Miyazaki T, Shimamura S, Nakayama H, Minematsu A, Yamauchi S, Takazono T, Nakamura S, Yanagihara K, Kohno S, Mukae H, Izumikawa K.

PLoS One. 2017 Jul 11;12(7):e0180990. doi: 10.1371/journal.pone.0180990. eCollection 2017.

45.

Risk Factors for Acquisition of Fluoroquinolone or Aminoglycoside Resistance in Addition to Carbapenem Resistance in Pseudomonas Aeruginosa.

Kosai K, Kaku N, Uno N, Saijo T, Morinaga Y, Imamura Y, Hasegawa H, Miyazaki T, Izumikawa K, Mukae H, Yanagihara K.

Open Microbiol J. 2017 May 31;11:92-97. doi: 10.2174/1874285801711010092. eCollection 2017.

46.

Efficacy and Pharmacokinetics of the Combination of OP0595 and Cefepime in a Mouse Model of Pneumonia Caused by Extended-Spectrum-Beta-Lactamase-Producing Klebsiella pneumoniae.

Kaku N, Kosai K, Takeda K, Uno N, Morinaga Y, Hasegawa H, Miyazaki T, Izumikawa K, Mukae H, Yanagihara K.

Antimicrob Agents Chemother. 2017 Jun 27;61(7). pii: e00828-17. doi: 10.1128/AAC.00828-17. Print 2017 Jul.

47.

Examination of cryptococcal glucuronoxylomannan antigen in bronchoalveolar lavage fluid for diagnosing pulmonary cryptococcosis in HIV-negative patients.

Oshima K, Takazono T, Saijo T, Tashiro M, Kurihara S, Yamamoto K, Imamura Y, Miyazaki T, Tsukamoto M, Yanagihara K, Mukae H, Kohno S, Izumikawa K.

Med Mycol. 2018 Jan 1;56(1):88-94. doi: 10.1093/mmy/myx010.

PMID:
28419364
48.

A case series of histoplasmosis patients with elevated serum soluble interleukin-2 receptor levels.

Hirayama T, Takazono T, Iwata K, Senju H, Shimazaki T, Tashiro M, Saijo T, Tanaka T, Nakamura S, Imamura Y, Kojiro M, Miyazaki T, Tsukamoto M, Furumoto A, Morimoto K, Muraosa Y, Matsubara Y, Yanagihara K, Mukae H, Kamei K, Kohno S, Izumikawa K.

J Infect Chemother. 2017 Sep;23(9):642-647. doi: 10.1016/j.jiac.2017.03.006. Epub 2017 Apr 8.

PMID:
28395939
49.

Pulmonary Actinomycosis Mimicking Pulmonary Aspergilloma and a Brief Review of the Literature.

Higashi Y, Nakamura S, Ashizawa N, Oshima K, Tanaka A, Miyazaki T, Izumikawa K, Yanagihara K, Yamamoto Y, Miyazaki Y, Mukae H, Kohno S.

Intern Med. 2017;56(4):449-453. doi: 10.2169/internalmedicine.56.7620. Epub 2017 Feb 15. Review.

50.

In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen.

Nishikawa H, Fukuda Y, Mitsuyama J, Tashiro M, Tanaka A, Takazono T, Saijo T, Yamamoto K, Nakamura S, Imamura Y, Miyazaki T, Kakeya H, Yamamoto Y, Yanagihara K, Mukae H, Kohno S, Izumikawa K.

J Antimicrob Chemother. 2017 Jun 1;72(6):1709-1713. doi: 10.1093/jac/dkx020.

Supplemental Content

Loading ...
Support Center